Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation
- PMID: 11809720
- DOI: 10.1093/hmg/11.2.115
Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation
Abstract
Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene. Previous data have shown that MECP2 RNA is present in all mouse and human tissues tested, but the timing of expression and regional distribution have not been explored. We investigated the spatial and temporal distribution of the MeCP2 protein during mouse and human development. We found that in the adult mouse, MeCP2 is high in the brain, lung and spleen, lower in heart and kidney, and barely detectable in liver, stomach and small intestine. There was no obvious correlation between protein levels and RNA levels, suggesting that translation may be post-transcriptionally regulated by tissue-specific factors. The timing of MeCP2 expression in mouse and human correlated with the maturation of the central nervous system, with the ontogenetically older structures such as the spinal cord and brainstem becoming positive before newer structures such as the hippocampus and cerebral cortex. In the cortex, MeCP2 first appeared in the Cajal-Retzius cells, then in the neurons of the deeper, more mature cortical layers, and finally in the neurons of the more superficial layers. The MeCP2 protein was eventually present in a majority of neurons but was absent from glial cells. Our data suggest that MeCP2 may become abundant only once a neuron has reached a certain degree of maturity, and that this may explain some aspects of the RTT phenotype.
Similar articles
-
Survey of MeCP2 in the Rett syndrome and the non-Rett syndrome brain.J Child Neurol. 2003 Oct;18(10):683-7. doi: 10.1177/08830738030180100601. J Child Neurol. 2003. PMID: 14649549
-
Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6033-8. doi: 10.1073/pnas.0401626101. Epub 2004 Apr 6. Proc Natl Acad Sci U S A. 2004. PMID: 15069197 Free PMC article.
-
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.Nat Genet. 2001 Mar;27(3):327-31. doi: 10.1038/85906. Nat Genet. 2001. PMID: 11242118
-
The neurobiology of Rett syndrome.Neuroscientist. 2003 Feb;9(1):57-63. doi: 10.1177/1073858402239591. Neuroscientist. 2003. PMID: 12580340 Review.
-
MeCP2 in neurons: closing in on the causes of Rett syndrome.Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R19-26. doi: 10.1093/hmg/ddi102. Hum Mol Genet. 2005. PMID: 15809268 Review.
Cited by
-
Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses.Sci Transl Med. 2012 Dec 5;4(163):163ra158. doi: 10.1126/scitranslmed.3004430. Sci Transl Med. 2012. PMID: 23220634 Free PMC article.
-
Epigenetic regulation of axon outgrowth and regeneration in CNS injury: the first steps forward.Neurotherapeutics. 2013 Oct;10(4):771-81. doi: 10.1007/s13311-013-0203-8. Neurotherapeutics. 2013. PMID: 23881454 Free PMC article. Review.
-
Epigenetic understanding of gene-environment interactions in psychiatric disorders: a new concept of clinical genetics.Clin Epigenetics. 2012 Jan 20;4(1):1. doi: 10.1186/1868-7083-4-1. Clin Epigenetics. 2012. PMID: 22414323 Free PMC article.
-
Up-regulated methyl CpG binding protein-2 in intractable temporal lobe epilepsy patients and a rat model.Neurochem Res. 2012 Sep;37(9):1886-97. doi: 10.1007/s11064-012-0804-3. Epub 2012 Jun 17. Neurochem Res. 2012. PMID: 22707285
-
Label-free three-photon imaging of intact human cerebral organoids for tracking early events in brain development and deficits in Rett syndrome.Elife. 2022 Jul 29;11:e78079. doi: 10.7554/eLife.78079. Elife. 2022. PMID: 35904330 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases